General
Preferred name
MIVACURIUM CHLORIDE
Synonyms
Mivacurium (dichloride) ()
Mivacron ()
BWB109OU ()
BW-B109OU DICHLORIDE ()
BW-B109OU ()
BW B109OU DICHLORIDE ()
mivacurium ()
BW-1090U DICHLORIDE ()
P&D ID
PD052326
CAS
106861-44-3
Tags
available
drug
Drug Status
approved
Max Phase
Phase 4
Drug indication
Neuromuscular Blocking Agent
First approval
1992
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Mivacurium is a nicotinic acetylcholine receptors (nAChRs) antagonist and a non-depolarizing neuromuscular-blocking drug metabolized by plasma cholinesterase.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
15
Molecular Weight
1098.5
Hydrogen Bond Acceptors
14
Hydrogen Bond Donors
0
Rotatable Bonds
28
Ring Count
6
Aromatic Ring Count
4
cLogP
3.04
TPSA
144.9
Fraction CSP3
0.52
Chiral centers
4.0
Largest ring
6.0
QED
0.04
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Neuroscience
Membrane Transporter/Ion Channel
Neuronal Signaling
Target
nAChR
Source data
